Logo-bi
Editorial
Khosro Adibkia* ORCID, Adel Mahmoudi Gharehbaba
Bioimpacts. 2026;16: 33099 | Published on: 2026 Jan 05. doi: 10.34172/bi.33099
PDFPDF
XMLXML
Cited By:
Original Article
Meryem Boutalaka ORCID, Noureddine Ouazzani, Mohamed Ouabane ORCID, Panagiotis Stathopoulos ORCID, Abdelkrim Guendouzi ORCID, Hamid Maghat, Alexios-Leandros Skaltsounis ORCID, Tahar Lakhlifi, Mohammed Bouachrine* ORCID
Bioimpacts. 2026;16: 31007 | Published on: 2026 Jan 05. doi: 10.34172/bi.31007
Graphical Abstract
Editorial
Robert C. Speth* ORCID
Bioimpacts. 2026;16: 33132 | Published on: 2026 Jan 05. doi: 10.34172/bi.33132
PDFPDF
XMLXML
Cited By:
Review
Reza Biglari ORCID, Majid Farshdousti Hagh, Khadijeh Abbasi, Maghsood Shaaker, Amir Mehdizadeh* ORCID
Bioimpacts. 2026;16: 32564 | Published on: 2026 Jan 05. doi: 10.34172/bi.32564
PDFPDF
XMLXML
Cited By:
Graphical Abstract
PDFPDF
XMLXML
Cited By:
Graphical Abstract

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge


Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons